bms 180448 has been researched along with bms 191095 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atwal, KS; Ferrara, FN; Green, DW; Grover, GJ; Monshizadegan, H; Rogers, WL; Sleph, P; Traeger, S; Wang, P | 1 |
| Atwal, KS; Bajgar, R; D'Alonzo, AJ; Darbenzio, RB; Garlid, KD; Grover, GJ; Hess, TA; Lodge, NJ; Paucek, P; Sleph, PG; Smith, MA | 1 |
| Burkett, DE; Grover, GJ; Parham, CS; Sadanaga, KK; Scalese, RJ | 1 |
| Ahmed, SZ; Atwal, KS; Baird, AJ; Ding, CZ; Dzwonczyk, S; Ferrara, FN; Grover, GJ; Humphreys, WG; McLaughlin, LG; Normandin, DE; Rovnyak, GC; Santafianos, D; Sleph, PG; Traeger, SC | 1 |
| Ahmed, SZ; Atwal, KS; Ding, CZ; Grover, GJ; Kelly, Y; Miller, AV; Misra, RN; Normandin, DE; Rovnyak, GC; Sleph, PG | 1 |
| Carroll, WA; Coghlan, MJ; Gopalakrishnan, M | 1 |
| Balsamo, A; Bianucci, AM; Calderone, V; Coi, A; Digiacomo, M; Rapposelli, S; Testai, L | 1 |
1 review(s) available for bms 180448 and bms 191095
| Article | Year |
|---|---|
Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.
Topics: Adenosine Triphosphate; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Calcium; Ion Channel Gating; Myocardial Ischemia; Potassium Channel Blockers; Potassium Channels; Urinary Incontinence | 2001 |
6 other study(ies) available for bms 180448 and bms 191095
| Article | Year |
|---|---|
Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitors.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Cardiotonic Agents; Cattle; Citrate (si)-Synthase; Electron Transport Complex IV; Hydrolysis; Imidazoles; In Vitro Techniques; Mitochondrial Proton-Translocating ATPases; Myocardial Contraction; Rats; Stereoisomerism; Structure-Activity Relationship | 2004 |
Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
Topics: Action Potentials; Animals; Benzopyrans; Cardiovascular Agents; Cromakalim; Decanoic Acids; Dose-Response Relationship, Drug; Glyburide; Guanidines; Guinea Pigs; Heart; Heart Conduction System; Hydroxy Acids; Imidazoles; In Vitro Techniques; Male; Mitochondria; Myocardial Ischemia; Myocardial Reperfusion; Papillary Muscles; Patch-Clamp Techniques; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Vasodilator Agents; Vasomotor System | 2001 |
Protective effect of mitochondrial KATP activation in an isolated gracilis model of ischemia and reperfusion in dogs.
Topics: Animals; Benzopyrans; Cardiotonic Agents; Dogs; Female; Guanidines; Imidazoles; Male; Membrane Proteins; Myocardial Ischemia; Potassium Channels; Reperfusion | 2003 |
Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 5. Identification of 4-(N-aryl)-substituted benzopyran derivatives with high selectivity.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Biological Availability; Glyburide; Heart; Potassium Channels; Rats; Structure-Activity Relationship | 1997 |
Cardioselective antiischemic ATP-sensitive potassium channel (K(ATP)) openers. 6. Effect of modifications at C6 of benzopyranyl cyanoguanidines.
Topics: Animals; Benzopyrans; Cardiotonic Agents; Glyburide; Guanidines; Heart; Muscle Contraction; Myocardial Ischemia; Potassium Channels; Rats; Vasodilation; Vasodilator Agents | 1999 |
Predictive models, based on classification algorithms, for compounds potentially active as mitochondrial ATP-sensitive potassium channel openers.
Topics: Algorithms; Benzopyrans; Cardiotonic Agents; KATP Channels; Models, Chemical; Molecular Structure; Quantitative Structure-Activity Relationship; Spiro Compounds | 2009 |